Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ALLR stock hub

Allarity Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ALLRis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

24M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ALLR

In the news

Latest news · ALLR

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-103.8

P25 -105.6P50 -46.5P75 -3.1

ROIC-64.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ALLR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

187

Groups with data

Currency

USD

Showing 187 of 187 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001860657
Company name	Allarity Therapeutics, Inc.
Country	United States
Country code	US
Cusip	016744500
Employees	8
Employees Change	1%
Employees Change Percent	14.29
Enterprise value	$10.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US0167445008
Last refreshed	2026-05-10
Market cap	$24M
Market cap category	Nano-Cap
Price	$1.55
Price currency	USD
Rev Per Employee	40,000x
Sector	Healthcare
Sic	2834
Symbol	ALLR
Website	https://www.allarity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-46.87%
EV/Sales	33.11x
FCF yield	-61.88%
P/B ratio	3x
P/S ratio	74.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$320,000
Net Income	$-11.2M
Net Income Growth Quarters	2%
Net Income Growth Years	1%
Pretax Margin	-3,509.69%
Profit Per Employee	$-1.4M
ROA	-38.52
Roa5y	-51.2
ROCE	-128.3
ROE	-103.8
ROIC	-64.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	50.53%
Cagr3y	-94.6%
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.02
Assets	$18.3M
Cash	$14.8M
Current Assets	$17.9M
Current Liabilities	$8.4M
Debt	$1.4M
Debt Equity	$0.14
Equity	$9.8M
Interest Coverage	-68.14
Liabilities	$8.4M
Long Term Assets	$330,000
Long Term Liabilities	$0
Net Cash	$13.4M
Net Cash By Market Cap	$55.79
Net Cash Growth	-26.76%
Net Debt Equity	$-1.36
Tangible Book Value	$9.8M
Tangible Book Value Per Share	$0.52
WACC	6.56

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.13
Net Working Capital	$-3.9M
Quick ratio	1.86
Working Capital	$9.5M
Working Capital Turnover	$0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-794.78%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	50.49%
200-day SMA	1.23
3Y total return	-99.98%
50-day SMA	1.23
50-day SMA vs 200-day SMA	50under200
All Time High	15,287,694.2
All Time High Change	-100%
All Time High Date	2021-12-21
All Time Low	0.61
All Time Low Change	152.53%
All Time Low Date	2025-04-09
ATR	0.11
Beta	0.38
Beta1y	0.37
Beta2y	0.52
Ch YTD	43.52
High	1.6
High52	2.35
High52 Date	2025-08-26
High52ch	-34.04%
Low	1.43
Low52	0.77
Low52 Date	2026-02-03
Low52ch	101.64%
Ma50ch	26.53%
Premarket Change Percent	-1.33
Premarket Price	$1.48
Premarket Volume	2,655
Price vs 200-day SMA	25.91%
RSI	69.71
RSI Monthly	9.82
RSI Weekly	26.6
Sharpe ratio	0.82x
Sortino ratio	1.64
Total Return	-794.78%
Tr YTD	43.52
Tr1m	33.62%
Tr1w	19.23%
Tr3m	86.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	1
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.22
Operating Income	$-12.6M
Operating margin	-3,939.1
Price target	$9.75
Price Target Change	$529

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,387,696%
Float Percent	99.53%
Shares Insiders	0.47%
Shares Institutions	7.35%
Shares Out	15,460,724
Shares Qo Q	8.32%
Shares Yo Y	794.78%
Short Float	1.94%
Short Ratio	2.48
Short Shares	1.93

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-15.5M
Average Volume	183,541.35x
Bv Per Share	0.52
CAPEX	$-8,000
Ch1m	33.62
Ch1w	19.23
Ch1y	50.49
Ch3m	86.59
Ch3y	-99.98
Ch6m	34.78
Change	3.33%
Change From Open	4.73
Close	1.5
Days Gap	-1.33
Depreciation Amortization	9,000
Dollar Volume	550,747.6
Earnings Date	2026-05-15
Earnings Time	amc
EBIT	$-12.6M
EBITDA	$-12.6M
EPS	$-0.78
F Score	1
FCF	$-14.8M
FCF EV Yield	-139.96x
FCF Per Share	$-0.96
Financing CF	10,648,000
Fiscal Year End	December
Founded	2,004
Investing CF	-8,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2024-09-11
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	1.19
Ma150ch	29.92%
Ma20	1.34
Ma20ch	15.59%
Net CF	-4,846,000
Next Earnings Date	2026-05-22
Open	1.48
Optionable	No
Position In Range	71.43
Post Close	1.55
Postmarket Change Percent	2.13
Postmarket Price	$1.58
Ppne	330,000
Pre Close	1.5
Price Date	2026-05-08
Ptbv Ratio	2.44
Relative Volume	1.94x
Revenue	320,000x
SBC By Revenue	213.13x
Share Based Comp	682,000
Tr6m	34.78%
Us State	Florida
Volume	355,321
Z Score	-10.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ALLR pay a dividend?

Capital-return profile for this ticker.

Performance

ALLR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ALLR?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.4%

Float: +99.5% of shares outstanding

Insider ownership

+0.5%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ALLR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.7

Neutral momentum band

Price vs 200-day MA

+25.9%

50/200-day relationship not available

Beta (5Y)

0.38

Less volatile than the market

Sharpe ratio

0.82

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ALLR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ALLR stock rating?

Allarity Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ALLR analysis?

The full report lives at /stocks/ALLR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ALLR?

The latest report frames ALLR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ALLR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.